This company listing is no longer active
MicroPort CardioFlow Medtech Vergangene Ertragsentwicklung
Vergangenheit Kriterienprüfungen 0/6
MicroPort CardioFlow Medtech's earnings have been declining at an average annual rate of -15.7%, while the Medical Equipment industry saw earnings growing at 12% annually. Revenues have been growing at an average rate of 27.3% per year.
Wichtige Informationen
-15.7%
Wachstumsrate der Gewinne
-8.3%
EPS-Wachstumsrate
| Medical Equipment Wachstum der Industrie | 13.7% |
| Wachstumsrate der Einnahmen | 27.3% |
| Eigenkapitalrendite | -15.9% |
| Netto-Marge | -91.0% |
| Letzte Ertragsaktualisierung | 30 Jun 2024 |
Jüngste Aktualisierungen vergangener Leistungen
Recent updates
Aufschlüsselung der Einnahmen und Ausgaben
Wie MicroPort CardioFlow Medtech Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.
Gewinn- und Umsatzhistorie
| Datum | Einnahmen | Umsatz | Allgemeine und Verwaltungskosten | F&E-Ausgaben |
|---|---|---|---|---|
| 30 Jun 24 | 383 | -349 | 297 | 211 |
| 31 Mar 24 | 360 | -410 | 295 | 224 |
| 31 Dec 23 | 336 | -472 | 293 | 237 |
| 30 Sep 23 | 319 | -491 | 273 | 246 |
| 30 Jun 23 | 303 | -511 | 253 | 254 |
| 31 Mar 23 | 277 | -483 | 243 | 239 |
| 31 Dec 22 | 251 | -454 | 233 | 224 |
| 30 Sep 22 | 245 | -345 | 213 | 203 |
| 30 Jun 22 | 239 | -236 | 193 | 182 |
| 31 Mar 22 | 220 | -209 | 173 | 166 |
| 31 Dec 21 | 201 | -183 | 152 | 151 |
| 30 Sep 21 | 176 | -265 | 131 | 133 |
| 30 Jun 21 | 151 | -346 | 111 | 116 |
| 31 Mar 21 | 128 | -372 | 104 | 106 |
| 31 Dec 20 | 104 | -398 | 97 | 97 |
| 31 Dec 19 | 22 | -145 | 37 | 97 |
Qualität der Erträge: 2160 is currently unprofitable.
Wachsende Gewinnspanne: 2160 is currently unprofitable.
Analyse von freiem Cashflow und Gewinn
Analyse des Gewinnwachstums in der Vergangenheit
Ergebnisentwicklung: 2160 is unprofitable, and losses have increased over the past 5 years at a rate of 15.7% per year.
Beschleunigtes Wachstum: Unable to compare 2160's earnings growth over the past year to its 5-year average as it is currently unprofitable
Erträge im Vergleich zur Industrie: 2160 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-7.3%).
Eigenkapitalrendite
Hohe Eigenkapitalrendite: 2160 has a negative Return on Equity (-15.92%), as it is currently unprofitable.